Published: Jan 12, 2026
Updated: Mar 19, 2026
.jpg)
One of the most complicated and challenging cancers to treat is ovarian cancer. International options such as Singapore are increasingly appealing to many patients in the United States, where healthcare expenses can be very high and access to certain breakthrough therapies may be limited. Singapore has become a leading hub for advanced cancer care, combining advanced medical technology with personalised patient support.
Singapore offers comprehensive and personalised oncology treatment plans, tailored to each patient's medical profile:
Singapore provides cutting-edge targeted therapy for advanced ovarian cancer based on evidence-based guidelines from the Agency for Care Effectiveness (ACE). PARP inhibitors, such as olaparib and niraparib, are commonly used as maintenance therapy for patients who respond to first-line platinum-based chemotherapy.Patients with homologous recombination deficit (HRD) or BRCA mutations benefit most from these therapies, which slow the course of the illness. PARP inhibitors may be used alone or in combination with the anti-angiogenic medication bevacizumab in certain situations.
Bevacizumab functions by preventing the development of new blood vessels that facilitate the growth of tumors. It improves progression-free outcomes in Singapore by being included in several chemotherapy and maintenance regimens, particularly for patients with high-risk or HRD-positive advanced ovarian cancer.
The cornerstone of advanced ovarian cancer treatment is still platinum-based chemotherapy, which is administered after cytoreductive surgery. Depending on the patient's condition and the stage of the disease, the timing and strategy are customised.
Hormone therapy may be used to prevent the formation or action of some ovarian cancer subtypes. Singapore provides comprehensive, multidisciplinary care that is in line with global best standards when combined with genetic testing and individualised treatment plans.
Key Ovarian Cancer Treatment Modalities
Treatment Modality | Overview | Typical Use Case |
Surgery (Cytoreductive Surgery) | Surgical removal of the ovaries, uterus, and visible tumour deposits | Primary or interval treatment to reduce tumour burden |
Chemotherapy | Platinum-based drug combinations such as carboplatin and paclitaxel | Given before or after surgery; also for recurrent disease |
Targeted Therapy (PARP Inhibitors) | Drugs like olaparib and niraparib that block DNA repair in cancer cells | Maintenance therapy after response to chemotherapy, especially in BRCA/HRD-positive patients |
Anti-Angiogenic Therapy (Bevacizumab) | Inhibits blood vessel growth that supports tumour development | Used with chemotherapy or as part of maintenance treatment |
Hormone Therapy | Therapies that block hormone production or hormone receptor activity | Selected hormone-sensitive ovarian cancer subtypes |
Personalised & Genetic-Based Care | BRCA and HRD testing to guide treatment decisions | Supports precision treatment planning |
One of the biggest considerations for US patients is treatment quality and cost. While Singapore isn't the cheapest medical tourism destination, many patients find it more predictable and sometimes more affordable than equivalent care in the US, especially without strong insurance coverage.
Country | Approx. Treatment Cost (USD) |
United States | $100,000 - $300,000+ (varies widely by treatment plan) |
$50,000 - $200,000 (estimates for ovarian cancer care) | |
$8,000 - $15,000 | |
$15,000 - $45,000 |
Singapore offers world-class care at often lower US treatment costs, especially for uninsured or high-deductible patients. However, prices vary by hospital, treatment complexity, and the technologies used.
a. Highly Skilled Specialists & Technological Excellence
Singapore's oncology teams, including gynaecologic oncologists and surgical specialists, train internationally and use state-of-the-art equipment backed by research and clinical expertise.
b. Multidisciplinary Care Approach
Cancer care in Singapore isn't just about treatment; it's about integrated care:
This collaborative model ensures that each ovarian cancer patient receives a tailored plan, improving outcomes compared with fragmented care.
c. Patient-Centred Support Services
Many hospitals provide:
Such services help international patients feel supported from arrival through recovery.
Patients typically come with at least one caregiver. Many choose long-stay accommodation or family-friendly apartments near hospitals.
Step | Duration |
Initial Consultation & Diagnostics | 1-3 days |
Treatment Planning & Scheduling | 1 week |
Surgery/Chemotherapy Course | Weeks to Months |
Follow-up Visits | Varies by plan |
Singapore emphasises continuity of care, which often includes:
This continuity reduces anxiety and ensures patients can resume care upon returning home.
While Singapore offers many strengths, it's important to consider:
Working with MediGence can help you streamline appointments, estimates, and travel logistics.
For many US patients with advanced ovarian cancer, Singapore represents a balance of world-class medical care, cutting-edge treatments, and cost predictability compared to domestic options. From personalised oncology plans to seamless international patient support, Singapore's healthcare ecosystem is designed to help patients focus on what matters most: recovery and quality of life.
If you're considering ovarian cancer treatment abroad, MediGence can assist with:
Contact us today to begin your journey toward advanced ovarian cancer care.

Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in the pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University. With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven pieces designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.

Dr. Vishwas Kaushik, an accomplished Belgorod State University graduate with an MBBS, is known for his impactful contributions to healthcare. Driven by a passion for global well-being, he seamlessly led domestic operations at VMV Group of Companies and orchestrated success at Clear Medi Cancer Centre. His adept team management and operational skills have positioned him as a luminary in healthcare tourism, shaping a future where compassionate, world-class medical care knows no boundaries.





Delhi, India

Istanbul, Turkey

Istanbul, Turkey

Istanbul, Turkey